Corante

About this author
Zack Lynch is author of The Neuro Revolution: How Brain Science Is Changing Our World (St. Martin's Press, July 2009).
He is the founder and executive director of the Neurotechnology Industry Organization (NIO) and co-founder of NeuroInsights. He serves on the advisory boards of the McGovern Institute for Brain Research at MIT, the Center for Neuroeconomic Studies, Science Progress, and SocialText, a social software company. Please send newsworthy items or feedback - to Zack Lynch.
Follow me on Twitter at @neurorev
Receive by email

GUEST AUTHOR ARCHIVES
THE NEURO REVOLUTION
TNRCoverWeb120.jpg Buy on Amazon
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

Brain Waves

« Neurosocieties: the rise and impact of the new brain sciences | Main | Wine and Tech Moguls Champion Neurotech »

November 27, 2007

Neurodevice Sector to See A Flowering of Startups

Email This Entry

Posted by Zack Lynch

MPO%20cover.pngCheck out the cover story of Medical Product Outsourcing magazine in December for an extensive article on the neurodevice sector titled Brain Power. Among the topics covered are the Neurotech Industry Organization's National Neurotechnology Initiative, the Neurotech Index and the an overview of neurodevice markets. From the article:

"In the neurodevice sector, three major markets have emerged, according to Lynch. The largest is the $2.5 billion neurosurgical market, consisting of tools used for procedures such as tumor removals or neurovascular interventions (such as to treat stroke victims) using coils, balloons, stents and other products. Neuromodulation, which encompasses stimulation devices used to restore function, is a $1.38 billion market. The final category is neuroprosthetics, a $540 million market consisting of products such as cochlear implants for hearing-impaired individuals, implants for spinal injuries and retinal implants (still in development). In addition to these markets, another emerging area is neurosoftware. Although it’s currently a small segment ($75 million in 2006), several companies are working on software for use leveraging neuroplasticity and neurofeedback, among others, said Lynch.

“One thing that’s interesting in the neurodevice market is there’s no one company that participates in all four segments. There’s no gorilla in the marketplace,” Lynch said. As a result of all the potential innovation in this somewhat untapped market, Lynch believes the industry will see “a flowering” of many startups in the neurodevice sector."

Comments (0) + TrackBacks (0) | Category: Neurodevices


POST A COMMENT

Thanks for signing in, . Now you can comment. (sign out)

(If you haven't left a comment here before, you may need to be approved by the site owner before your comment will appear. Until then, it won't appear on the entry. Thanks for waiting.)





Remember me?


EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
Neurotech 2010: Translational Researchers Highlight Innovation
The Neuro Revolution in China Progressing
Speakers for Neurotech 2010 - Boston, May 19-20
Giving the Brain a Voice: NIO Public Policy Tour in DC tomorrow
McGovern Institue for Brain Research at MIT Goes Web 2.0
The Neurodiagnostics Report 2010: Brain Imaging, Biomarkers and NeuroInformatics
Neuropharma FDA Approvals Down in 2009
Tel Aviv Neurotech Cluster Thrives